Cablegate: Ottawa Response: Demarche On Codex Meeting On

This record is a partial extract of the original cable. The full text of the original cable is not available.

UNCLAS OTTAWA 003301

SIPDIS

SENSITIVE

E.O. 12958: N/A
TAGS: ECON ETRD FDA
SUBJECT: OTTAWA RESPONSE: DEMARCHE ON CODEX MEETING ON
INFANT FORMULA STANDARDS

REF: SECSTATE 202287

(SBU) 1. Econoff provided talking points to specified Health
Canada contact Christina Zehaluk on November 4, 2005. Ms.
Zehaluk said that the GOC would support a higher level for
added nucleotides, and if 16mg/kcal was "the number on the
table" she felt that the GOC could probably support that,
based on current added levels in products for sale in Canada
and the United States. Ms. Zehaluk did mention, however,
that she does not feel that this is the most important topic
under consideration at the upcoming meeting, and she is
suprised at the level of attention it is getting.

Visit Canada's Classified Web Site at
http://www.state.sgov.gov/p/wha/ottawa

WILKINS

© Scoop Media